This Week's Poll

At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you

Supported by Medilink UK

SME voice in market - Peter Ellingworth of - ABHI - 14:15:51pm Jun-16th

It is vitally important for the SME voice within the medical technology and healthcare market, and the life sciences sector as a whole, to be heard and appreciated. This is a strong theme from the report which industry and government has recently published and for which an action plan is now getting underway. As a majority stakeholder in medical manufacturing, the UK SME community plays a vital role in the growth and prosperity of larger businesses with its quick response times, competitive pricing and entrepreneurial spirit.

Agree/Disagree + add comment
 
 
t